ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 78 filers reported holding ALDEYRA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 1.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $487,000,000 | – | 92,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 484,096 | $6,317,000 | 5.34% |
| CVI Holdings, LLC | 200,000 | $2,760,000 | 4.56% |
| Mesirow Financial Investment Management, Inc. | 38,097 | $526,000 | 2.71% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,142,089 | $15,761,000 | 1.81% |
| 683 Capital Management, LLC | 1,350,000 | $18,630,000 | 1.21% |
| Stonepine Capital Management, LLC | 145,000 | $2,001,000 | 1.17% |
| Perceptive Advisors | 3,085,458 | $42,579,000 | 1.14% |
| EAM Investors, LLC | 312,092 | $4,307,000 | 0.64% |
| MANGROVE PARTNERS IM, LLC | 707,746 | $9,767,000 | 0.62% |
| EAM Global Investors LLC | 86,614 | $1,195,000 | 0.48% |